Category: Drug Safety Alerts
-
Safety “Cloud” Gets Removed From Spiriva By FDA In January 2010
This COPD Medication Had Previously Been Possibly Linked To Stroke, Heart Attack, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) On January 14, 2010 the FDA issued a news release, "FDA Updates Earlier Guidance…
-
FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure
FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October…
-
Levaquin Has Been Associated With Dysglycemia Events Such As Hyperglycemia And Hypoglycemia
North Carolina Case Report: Man With Diabetes Develops Low Blood Sugar After Using Levaquin Together With Glucotrol (Posted by Tom Lamb at DrugInjuryWatch.com) Three years ago to the day we posted an article, back in…
-
December 2009: Voltaren Gel And Other Products Containing Diclofenc Sodium Linked To Liver Problems
"Dear Doctor" Letter From Endo And Novartis Offers Information About Prevention And Diagnosis Of Drug-Induced Liver Injury (DILI) (Posted by Tom Lamb at DrugInjuryWatch.com) On December 4, 2009 the FDA issued this MedWatch alert, "Voltaren…
-
Diet Drug Meridia Has Possible Cardiovascular Risks, Including Stroke, Heart Attack, And Cardiac Death
FDA Early Communication About Meridia (Sibutramine) Side Effects Issued by Agency In November 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid FDA Safety Concerns (10/8/10, Bloomberg) Abbott…
-
Anemia Drugs Procrit And Aranesp May Increase Twofold The Risk Of Potentially Fatal Blood Clots
Results From Large Long-Term Study Show Association Between These Erythropoiesis-Stimulating Agents And Venous Thromboembolism (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2009 we learned that the results from the Trial to Reduce Cardiovascular…
-
Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease
TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The anemia drug Aranesp (darbepoetin alfa) might cause an increased…
-
Diabetes Drug Byetta Linked To Kidney Problems And Cases Of Renal Failure
October 2009 Byetta Label Change Follows Earlier Alert From U.K. About Kidney-Related Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2009 the Drug Safety Update Newsletter alerted us about reports of kidney-related…
-
FDA Wants Merck To Change Januvia Label With Increased Warning About Pancreatitis Risk
Is Januvia Similar To Byetta In Terms Of The So-Called Class Effect And Drug Injury Lawsuits Being Filed? (Posted by Tom Lamb at DrugInjuryWatch.com) On September 25, 2009 the FDA posted on its web…